Cargando…

Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer

Compared with other types of breast cancer, triple-negative breast cancer (TNBC) has the characteristics of rapid progression, a lack of specific molecular targets for treatment and a poor prognosis. However, based on previously published studies, TGF-β1 and survivin are potentially meaningful for t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Nannan, Qi, Dongxue, Jiang, Jing, Zhang, Jihong, Yu, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073572/ https://www.ncbi.nlm.nih.gov/pubmed/35527782 http://dx.doi.org/10.3892/ol.2022.13313

Ejemplares similares

Expression pattern of p-Smad2/Smad4 as a predictor of survival in invasive breast ductal carcinoma
por: Liu, Nannan, et al.
Publicado: (2020)

High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma
por: Shi, Chun-Tao, et al.
Publicado: (2019)

Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2021)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
por: Wu, Guoyu, et al.
Publicado: (2022)

Deptor Enhances Triple-Negative Breast Cancer Metastasis and Chemoresistance through Coupling to Survivin Expression()()
por: Parvani, Jenny G., et al.
Publicado: (2015)

Pirfenidone suppressed triple‐negative breast cancer metastasis by inhibiting the activity of the TGF‐β/SMAD pathway
por: Luo, Daiqin, et al.
Publicado: (2023)

Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
por: Tian, Jun, et al.
Publicado: (2017)

4543 Glucocorticoid Receptors are essential effectors of TGFβ signaling in Triple Negative Breast Cancer
por: Kerkvliet, Carlos Jesus Perez, et al.
Publicado: (2020)

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression
por: López-Tejada, Araceli, et al.
Publicado: (2023)

TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity
por: Panagi, Myrofora, et al.
Publicado: (2020)

SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
por: Zhang, Z, et al.
Publicado: (2017)

TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
por: Wardhani, Bantari WK, et al.
Publicado: (2020)

Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands
por: SenGupta, Shuvasree, et al.
Publicado: (2021)

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer
por: Garlapati, Chakravarthy, et al.
Publicado: (2023)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling
por: Jiang, Hong-Lin, et al.
Publicado: (2015)

DGKZ promotes TGFβ signaling pathway and metastasis in triple-negative breast cancer by suppressing lipid raft-dependent endocytosis of TGFβR2
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

A plasma protein derived TGFβ signature is a prognostic indicator in triple negative breast cancer
por: Katayama, Hiroyuki, et al.
Publicado: (2019)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
por: Martini, Silvia, et al.
Publicado: (2021)

Clinicopathological significance of Sox10 expression in triple-negative breast carcinoma
por: Jin, Linfang, et al.
Publicado: (2020)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Significance of Nuclear Factor-Kappa B (NF-κB) and Survivin in Breast Cancer and Their Association with Radiosensitivity and Prognosis
por: Cao, Qian, et al.
Publicado: (2023)

Expression and clinical significance of MAPK and EGFR in triple-negative breast cancer
por: Jiang, Weihua, et al.
Publicado: (2020)

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
por: Jalalirad, Mohammad, et al.
Publicado: (2021)

HTR1A Inhibits the Progression of Triple‐Negative Breast Cancer via TGF‐β Canonical and Noncanonical Pathways
por: Liu, Qiqi, et al.
Publicado: (2022)

TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-β to Mediate EMT in Triple-Negative Breast Cancer
por: Tong, Jiaci, et al.
Publicado: (2022)

Biological and clinical significance of flap endonuclease-1 in triple-negative breast cancer: Support of metastasis and a poor prognosis
por: Xu, Lu, et al.
Publicado: (2020)

Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1
por: Zhang, Jingnan, et al.
Publicado: (2023)

TGF-β1 regulates cell fate during epithelial–mesenchymal transition by upregulating survivin
por: Lee, J, et al.
Publicado: (2013)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Significance of E-cadherin expression in triple-negative breast cancer
por: Kashiwagi, S, et al.
Publicado: (2010)

Clinical significance of morphologic characteristics in triple negative breast cancer
por: Ryu, Dong Won, et al.
Publicado: (2011)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
por: Kim, Sangmin, et al.
Publicado: (2015)

Anti‐pyroptotic function of TGF‐β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells
por: Tamura, Yusuke, et al.
Publicado: (2021)

ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer
por: Chen, Mingcang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_csi7fq00sl497cbh061f3e229c